Multi-Drug Therapy Followed By Rituximab in Children with Refractory Nephrotic Syndrome Contributors

Journal Title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) - Year 2018, Vol 17, Issue 1

Abstract

Introduction: Over the last few years, rituximab (RTX) has emerged as a second- line therapy and has shown a 40-48% response rate in steroid resistant and up to 80% remission rate in steroid dependent nephrotic syndrome. The better outcome of RTX therapy in dependent nephrotic syndrome compared to resistant nephrotic syndrome is possibly due to excessive loss of RTX in the urine during active state of proteinuria. Objective: To assess the therapeutic response of RTX during non-proteinuric state in children with steroid and CNIs/MMF resistance nephrotic syndrome following induction of remission by a combined therapy of Prednisolone, CNIs and MMF. Materials and Methodology: In this study we analysed the data of steroid and CNIs/MMF –resistance idiopathic nephrotic children, aged 1-14 years from January 2014 to January 2016. The clinical decision was to treat those patients with a combined therapy (Prednisolone+CNI+MMF) to achieve remission, followed by treatment with RTX at a dose of 375 mg/m2 body surface area per week for two to four weeks. Five children those who responded to triple regimen were treated with two to four doses of RTX and were followed up for minimum six months following RTX therapy. Post RTX therapy, CNI and prednisolone dose was tapered. Results and Discussion: The characteristics of the five patients and follow-up data were documented Patient 1 and 2 were twin brothers. At six months follow-up, four patients achieved complete remission (80%) and three patients (60%) were completely off medications without any serious adverse effects. Conclusion: Ourstudy showed improved RTX efficacy during non-proteinuric state of refractory nephrotic syndrome. However, as intense immunosuppression may cause serious adverse event further study for evaluatinglong-term efficacy and safety of multidrug therapy are needed.

Authors and Affiliations

r. Saroj Kumar Satpathy, Dr. Subal Kumar Pradhan, Dr. Akhil Krishnamoorthy, Dr. Shreesh Bhat

Keywords

Related Articles

Assessment of Awareness and willingness of Eye Donation among Medical Students in Central India

The Cornea is the clear tissue covering the front of the eye. It is a focusing element of the eye. The vision is dramatically reduced or lost if the cornea becomes cloudy. This loss of the vision is referred to as cornea...

Neurological Disorders in Pregnancy and Puerperium

Objectives: To study the clinical profile of the patients presenting with neurological disorders during pregnancy and puerperium. Methods: The study was carried out at Father Muller Medical College, Karnataka, India betw...

“In Vitro Comparision of Flexural Strength of Cention-N, BulkFill Composites, Light-Cure Nanocomposites And Resin-Modified Glass Ionomer Cement”

Cention-N is recently introduced material. So, the aim of this study is to compare the flexural strength of Cention-N, Resin-modified glass ionomer cement, bulk-fill composite & light-cure nanocomposite. In this study, f...

Agar Gel Alkaline Electrophoresis As A Cost Effective Screening Modality For Abnormal Hemoglobins

Alkaline agar gel electrophoresis is a basic manual laborious technique for identifying Hemoglobin variants in the screening for Hemoglobinopathies. It’s a cheaper alternative to the now preferred method of detection of...

Prevalence And Determinants of Benign Prostatic HyperplasiaAmong Males Attending Primary Health Care Clinics At KFMMC, Dhahran, Eastern Region, KSA

Background: The benign prostatic hyperplasia is of significant importance to public health, affecting tens of millions of older men globally. Objectives: To determine the prevalence, investigate risk factors, and to clar...

Download PDF file
  • EP ID EP262843
  • DOI 10.9790/0853-1701010
  • Views 68
  • Downloads 0

How To Cite

r. Saroj Kumar Satpathy, Dr. Subal Kumar Pradhan, Dr. Akhil Krishnamoorthy, Dr. Shreesh Bhat (2018). Multi-Drug Therapy Followed By Rituximab in Children with Refractory Nephrotic Syndrome Contributors. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), 17(1), 5-9. https://europub.co.uk./articles/-A-262843